Johnson & Johnson Named Inaugural Global Impact Award Winner by the Healthcare Businesswomen's Association

Published on February 9, 2026
FAIRFIELD, N.J.—Johnson & Johnson (NYSE: JNJ) has been named the inaugural recipient of the Global Impact Award by the Healthcare Businesswomen's Association (HBA), a global leadership accelerator, business growth partner, and enterprise solution for the health care and life sciences industries. The HBA's first-ever Global Impact Award recognizes organizations whose leadership practices, innovation strategies, collaboration models, and business performance work together to drive meaningful, sustained change across health care and life sciences, the announcement noted.
Continue reading on website
Other news

What to know about the most recent treatment and management developments in AMD | Optometry Times - Clinical News

February 8, 2026
In recent months, developments have ranged from regulatory setbacks to real-world data releases.

SpyGlass Pharma Raises $150 Million in Initial Public Offering

February 9, 2026
ALISO VIEJO, Calif.—SpyGlass Pharma, Inc. (Nasdaq: SGP), a late-stage biopharmaceutical company focused on intraocular lens and drug delivery solutions for chronic eye conditions such as glaucoma, announced it raised $150 million in its initial public offering (IPO). The IPO priced 9,375,000 shares of common stock at $16 per share.